1 completed, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow GREAT Network Italy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adrecizumab Dose Escalation Safety and Tolerability Evaluation (ADESTE) Adrecizumab - Acute Heart Failure | Phase 2 | Unknown | GREAT Network Italy | 30 | 2019-12-15 | 2021-03-09 |
| Biomarker Rule in/Out in Patients With Acute Diseases for Validation of AKI (BRAVA) Acute Kidney Injury Urine-TIMP-IGFBP7 biomarker for AKI - Acute Kidney Injury | Completed | GREAT Network Italy | 818 | 2018-11-01 | 2021-03-09 |
Acute Kidney Injury (1) · Emergencies (1)
enibarcimab (1)
Australia (1) · India (1) · Indonesia (1) · Singapore (1) · South Korea (1) · Thailand (1)